CALPINE CORP Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net
CALPINE CORP reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $1.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-25.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2020-02-25
- CALPINE CORP derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- CALPINE CORP derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2018-09-30 was $0.00.
- CALPINE CORP derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2018-06-30 was $1.00M.
- CALPINE CORP derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-12-31 was $1.00M.
- CALPINE CORP derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2018 was $1.00M, a 0.00% change from fiscal 2017.
- CALPINE CORP derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2017 was $1.00M.
- CALPINE CORP derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2016 was $0.00.
- CALPINE CORP derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2015 was $0.00.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $1.00M derived: sum of 3 quarters · filed 2020-02-25 | $1.00M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-08 | $1.00M derived: sum of 2 quarters · filed 2019-11-08 | $1.00M 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $1.00M 10-Q · filed 2019-08-08 | $1.00M 10-Q · filed 2019-08-08 | |||
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.00M derived: sum of 2 quarters · filed 2020-02-25 | $1.00M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | |||
| 2017-03-31 | $1.00M 10-K · filed 2018-02-16 | ||||
| 2016-12-31 | $0.00 10-K · filed 2018-02-16 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-16 | ||||
| 2014-12-31 | $0.00 10-K · filed 2015-02-13 | ||||
| 2013-12-31 | $0.00 10-K · filed 2015-02-13 | ||||
| 2012-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$4.00M derived: sum of 2 quarters · filed 2015-02-13 | -$4.00M derived: sum of 3 quarters · filed 2015-02-13 | -$2.00M 10-K · filed 2015-02-13 | $2.00M 10-K · filed 2013-02-13 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $2.00M 10-Q · filed 2013-11-07 | $2.00M derived: sum of 4 quarters · filed 2014-02-13 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-07-25 | $2.00M 10-Q · filed 2013-07-25 | $2.00M derived: sum of 3 quarters · filed 2014-02-13 | $0.00 derived: sum of 4 quarters · filed 2014-02-13 | |
| 2012-03-31 | $2.00M 10-Q · filed 2013-05-02 | $2.00M derived: sum of 2 quarters · filed 2014-02-13 | $0.00 derived: sum of 3 quarters · filed 2014-02-13 | $0.00 derived: sum of 4 quarters · filed 2014-02-13 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | -$2.00M derived: sum of 2 quarters · filed 2014-02-13 | -$2.00M derived: sum of 3 quarters · filed 2014-02-13 | -$2.00M 10-K · filed 2014-02-13 | -$3.00M 10-K · filed 2012-02-10 |
| 2011-09-30 | -$2.00M 10-Q · filed 2012-11-06 | -$2.00M derived: sum of 2 quarters · filed 2012-11-06 | -$2.00M 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $0.00 10-Q · filed 2012-07-27 | $0.00 10-Q · filed 2012-07-27 | |||
| 2011-03-31 | $0.00 10-Q · filed 2012-04-27 | ||||
| 2010-12-31 | $0.00 10-K · filed 2012-02-10 | ||||
| 2010-09-30 | -$1.00M 10-Q · filed 2011-10-28 | $2.00M derived: sum of 2 quarters · filed 2011-10-28 | |||
| 2010-06-30 | $3.00M 10-Q · filed 2011-07-29 | $1.00M 10-Q · filed 2011-07-29 |